[A new approach to the therapy of hypertensive states].
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002191:Canrenoic Acid / Q000627:therapeutic use*; D004232:Diuretics; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011245:Pregnadienes / Q000627:therapeutic use*; D012110:Reserpine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D011245:Pregnadienes; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; C006445:althiazide, canrenoate potassium, rescinnamine drug combination; D002191:Canrenoic Acid; D012110:Reserpine
Un nuovo approccio per la terapia degli stati ipertensivi.